| 1 |
31281722 | Doxorubicin Promotes Migration and Invasion of Breast Cancer Cells through the Upregulation of the RhoA/MLC Pathway. | 2019 Jun |
4 |
| 2 |
33817200 | RHOA and mDia1 Promotes Apoptosis of Breast Cancer Cells Via a High Dose of Doxorubicin Treatment. | 2019 Jan |
1 |
| 3 |
28502289 | Chronophin activation is necessary in Doxorubicin-induced actin cytoskeleton alteration. | 2017 Jun |
3 |
| 4 |
22571463 | The transcription factor GCF2 is an upstream repressor of the small GTPAse RhoA, regulating membrane protein trafficking, sensitivity to doxorubicin, and resistance to cisplatin. | 2012 Jun 4 |
1 |
| 5 |
18463201 | Activation of nuclear factor-kappa B pathway by simvastatin and RhoA silencing increases doxorubicin cytotoxicity in human colon cancer HT29 cells. | 2008 Aug |
4 |
| 6 |
18754886 | Extracellular matrix proteins protect human HT1080 cells against the antimigratory effect of doxorubicin. | 2008 Aug |
1 |
| 7 |
18922976 | RhoA silencing reverts the resistance to doxorubicin in human colon cancer cells. | 2008 Oct |
6 |
| 8 |
16450390 | Statins revert doxorubicin resistance via nitric oxide in malignant mesothelioma. | 2006 Jul 1 |
1 |
| 9 |
15448013 | Reversal of the malignant phenotype of gastric cancer cells by inhibition of RhoA expression and activity. | 2004 Sep 15 |
2 |